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Summary
An operon consisting of three open reading frames,
annotated in silico as methylmalonyl-CoA (mm-CoA)
epimerase, mm-CoA mutase (MCM), and meaB, was
identified in the sequencing project of the myxobacte-
rium Sorangium cellulosum So ce56. This putative
MCM pathway operon was subcloned from a bacterial
artificial chromosome by Red/ET recombineering onto
a minimal replicon derived from p15A. This plasmid
was modified for integration and heterologous expres-
sion in Pseudomonas putida to enable the production
of complex secondary metabolites requiring mm-CoA
as precursor. Methylmalonate was identified in the
recombinant P. putida strain by an analysis method
based on gas chromatography/mass spectrometry.
The engineered strain is able to synthesize polyketi-
des requiring mm-CoA as an extender unit, which
was demonstrated by the production of myxothiazol
after integration of the biosynthetic gene cluster into
the chromosome, followed by induction of expression.
Introduction
The variety and number of metabolites produced in the
natural world is astonishing. Over 100,000 secondary
metabolites with a molecular weight less than 2,500 Da
have been described, mainly isolated from microbes
and plants [1]. Natural products are synthesized starting
from small molecules by multiple enzymatic steps [2]
and classified according to the building blocks used to
*Correspondence: youming.zhang@genebridges.com (Y.Z.), rom@
mx.uni-saarland.de (R.M.)build up the metabolite (e.g., polyketides or nonribo-
somally synthesized peptides). The polyketides are
synthesized from acyl-CoA precursors by polyketide
synthases (PKS) in a reaction scheme that is related to
fatty acid biosynthesis. Nonribosomally generated pep-
tides are assembled by nonribosomal peptide synthe-
tases (NRPS) with proteinogenic and unusual amino
acids, as well as a-hydoxy and carboxylic acids [3].
Natural products are significant because they often
exhibit biological activities, such as antibiotics, cyto-
statics, insecticidals or antifungals [4]. The problem of
emerging resistance emphasizes the need to search
for new drugs. Within this process, the discovery and
exploitation of new resources is considered important
[5]. One possibility is the activation of ‘‘silent’’ biosyn-
thetic gene clusters revealed by microbial genome
projects [5]. Even well-known producers of secondary
metabolites, such as Streptomyces coelicolor A3(2) or
S. avermitilis, harbor many more biosynthetic gene clus-
ters than anticipated [6, 7]. Another resource might be
metagenomes, which represent the genetic information
of a specific location at a certain point in time for all
microorganisms, including those not cultivatable [5]. A
further possibility is the mining of microorganisms
from ecological niches [8]. Searching for new activities
in these sources, particularly in metagenomes, depends
upon well-behaved and well-characterized heterolo-
gous expression systems. There are several examples
of heterologous expression of biosynthetic pathways
from microorganisms in closely related genera [5, 9].
Heterologous expression of secondary metabolites in
unrelated hosts is also manageable. For example,
Escherichia coli was genetically modified in several
steps to produce 6-deoxyerythronolide (6-dEB), the
aglycone of the antibiotic erythromycin [10]. More
recently, we used P. putida KT2440 to express the
myxobacterial myxochromide PKS/NRPS hybrid gene
cluster [11]. The production was possible because
P. putida provided all the building blocks for the biosyn-
thesis of myxochromide, including a broad-spectrum
phosphopantetheinyl transferase capable of posttrans-
lational activation of the carrier domains in the PKS/
NRPS hybrid [12].
Many polyketides require methylmalonyl-CoA (mm-
CoA) as an extender unit for the incorporation of C3 units.
mm-CoA can be synthesized in two ways: first, through
the action of propionyl-CoA carboxylase (PCC); and,
second, in the reverse reaction of the mm-CoA mutase
(MCM) and epimerase pathway from succinyl-CoA
(Figure 1). Propionyl-CoA is a central metabolite in the
degradation of the amino acids L-met, L-ile and L-val. It
is also the end product in the degradation of uneven fatty
acids by b-oxidation. According to biochemistry text-
books, propionyl-CoA is carboxylated to (2S)-mm-CoA
by the biotin-dependent PCC. The racemization of
(2S)-mm-CoA into its (2R)-stereoisomer is catalyzed by
mm-CoA epimerase. (2R)-mm-CoA is then the substrate
for the cobalamine-dependent MCM in the formation of
succinyl-CoA, which is part of the Krebs cycle (Figure 1)
[13, 14]. mm-CoA was not detected in pseudomonads
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MCM, mm-CoA mutase; MeaB, mm-CoA mutase enzyme complex protecting protein; Epi, mm-CoA epimerase; Pcc, propionyl-CoA
carboxylase.[15], although they can grow with L-val and L-ile as sole
carbon source (Figure 1). As mm-CoA is not made in P.
putida in detectable levels, metabolic engineering is re-
quired to supply the necessary extender units for biosyn-
thesis of mm-CoA-dependent secondary metabolites.
Myxobacteria are a prominent resource of secondary
metabolites [16, 17], and genetic studies on the biosyn-
thesis of the respective compounds are emerging [18]. It
can be assumed that myxobacteria harbor genes re-
sponsible for the formation of mm-CoA, because of their
capacity to produce polyketide-type secondary metab-
olites with mm-CoA as extender units (e.g., epothilone
[19–21], soraphen [16, 22, 23], or myxothiazol [24, 25]).
In this study, we report the identification of an operon
encoding an mm-CoA epimerase (EC 5.1.99.1), MCM
(EC 5.4.99.2), and an enzyme complex-stabilizing factor,
MeaB, in the ongoing genome sequencing project of
the myxobacterium Sorangium cellulosum So ce56
(Figure 1). We report the heterologous expression of
this operon in P. putida, KT2440, and the identification
of mm-CoA in the recombinant Pseudomonas strain,
by a new isotope dilution analysis method based on
gas chromatography coupled with mass spectrometry.
mm-CoA enabled the heterologous production of the
myxobacterial secondary metabolite, myxothiazol, in
this engineered strain.
Results
Identification of the mm-CoA operon
in S. cellulosum
An operon consisting of three open reading frames
(ORFs) was identified in the genome of S. cellulosum
So ce56 when MCM and mm-CoA epimerase from
Propionibacterium freudenreichii shermanii were used
as query in BLASTP [26] searches. The third ORF
(meaB), which exhibits similarity to lysine/arginine/orni-
thine (LAO) transport proteins, is located downstream of
the mutase gene. Such proteins are conserved neigh-
bors of prokaryotic mcm genes and are, therefore, con-
sidered to be involved in propionyl-CoA metabolism
[27]. The arrangement of the operon is depicted in Fig-
ure 2A, and an alignment of the predicted MCM is shown
in Figure 2B.
The predicted mm-CoA epimerase (epi) is 519 nucleo-
tides long, with no clearly identifiable ribosome bindingsite (RBS) in the immediate vicinity upstream of the pro-
posed ATG start codon, and the deduced protein (172
amino acids) shows greatest similarity to predicted
glyoxylases/bleomycin resistance genes (lactoglutha-
tione [LGSH] lyase family) from Solibacter usitatus
Ellin6076 (ZP_00519667; identities: 98/149 [65%]; posi-
tives: 125/149 [83%]), Nocardioides sp. JS614
(ZP_00656876; identities: 58/151 [38%]; positives: 87/
151 [57%]), and to a predicted mm-CoA epimerase
fromGeobacter sulfurreducensPCA (NP_954343; identi-
ties 59/139 [42%]; positives: 83/139 [59%]). The coding
sequences of the predicted epimerase and mutase
overlap for nine nucleotides (.CATGGATGAC.), indi-
cating a coupled translation.
The ORF encoding the predicted MCM (mcm) is 2649
nucleotides in size, and a putative RBS (GAGG) can be
found 12 nucleotides upstream of the proposed ATG
start codon, with no alternative start codon in the imme-
diate vicinity. The deduced protein (882 amino acids, 95
kDa) shows greatest similarities to the MCMs of Chloro-
flexus aurantiacus (ZP_00358667; identities: 460/670
[68%]; positives: 537/670 [80%]) and Leptospira inter-
rogans serovar Copenhageni str. Fiocruz L1-130
(YP_003598; identities: 460/677 [67%]; positives: 539/
677 [79%]). All known MCMs function as dimers. The
genes for MCM from P. freudenreicheii shermanii [28],
Streptomyces cinnamonensis [29], E. coli [30], humans
[31], and mice [32] have been cloned and sequenced.
The enzymes from P. freudenreichii shermanii and S.
cinnamonensis are heterodimers of two homologous
subunits: a subunit (w79 kDa) and b subunit (w65 kDa)
[28, 29]. The other three enzymes are homodimers
(w79 kDa) [30–32]. No second subunit could be identi-
fied in the S. cellulosum So ce56 genome, which sug-
gests that the active protein is a homodimer. It carries
an N-terminal tail of approximately 150–200 amino acids,
which shows approximately 30% identity with a part of
the small subunits of other MCMs (data not shown).
This homology is not detected when the whole peptide
is used as input sequence in the BLASTP search; align-
ments then start around amino acid 200 of the sequence.
An alignment of MCM with some other selected MCMs
is shown in Figure 2B.
The ORF of meaB is 993 nucleotides in size, and
a putative RBS (GAGG) is located 9 nucleotides up-
stream of the proposed TTG start codon. The stop
Heterologous Biosynthesis of Methylmalonyl-CoA
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(A) Methylmalonyl-CoA mutase pathway—genetic organization in the S. cellulosum So ce56 genome. epi, methylmalonyl-CoA epimerase;
mcm, methylmalonyl-CoA mutase; meaB, complex stabilizing protein; regulatory, regulatory protein; conserved, conserved hypothetical
protein
(B) Aligment of selected MCM performed with ClustalW. Propionibac, P. freudenreichii shermanii, a-subunit (P11653); Streptomyces,
Streptomyces cinneamonensis, a-subunit (Q05065); Chloroflexus, Chloroflexus aurantiacus (Q3DXY6); Leptospira, Leptospira interrogans sv
copenhageni (Q75FI0); Sorangium, S. cellulosum So ce56; E. coli, E. coli sbm (P27253).codon of mcm is separated by one nucleotide from the
start-codon of meaB (.CTAGGTTGA.), indicating
that all three genes build one transcriptional unit. The
deduced protein, MeaB (330 amino acids), shows great-
est similarities to ArgK, a member of the LAO transport
protein family from Solibacter usitatus Ellin6076
(ZP_00519926; identities: 183/298 [61%]; positives:
218/298 [73%]).
The ORF upstream of epi, annotated as positive regu-
lator ofs activity, is transcribed in the opposite direction,
and the ORF downstream of meaB shows no significant
similarity to any deposited sequence in the databases,
and is separated by 92 nucleotides from the stop codon
of meaB. Therefore, we concluded that the three-gene
operon is responsible for mm-CoA formation in S. cellu-
losum So ce56. Because the genes identified show
similar codon usage to P. putida, we subsequently
intended to verify the in silico annotation by heterolo-
gous expression in this strain. A further benefit wouldbe the creation of a host organism suitable for heterolo-
gous expression of polyketide biosynthetic gene clus-
ters, requiring mm-CoA as extender unit.
Heterologous Expression of the Operon in P. putida
and Quantitative Analysis of mm-CoA Formation
in the Engineered Strain, FG2005
The three ORFs were subcloned from a BAC in the geno-
mic library of S. cellulosum So ce56 [16] onto a minimal
p15A replicon by Red/ET subcloning [33, 34]. After PCR
amplification of the minimal replicon with oligonucleo-
tides incorporating 50 nucleotides homology to the start
and end of the operon, plasmid p15A-amp mutase was
generated (Figure 3A). For integration into the P. putida
chromosome by homologous recombination, homology
regions were inserted into the expression plasmid
up- and downstream of the operon. This was done by
a recombineering technique called triple recombination
involving two linear PCR fragments and the circular
Chemistry & Biology
1256Figure 3. MCM Pathway Expression Plasmid
(A) Construction by Red/ET subcloning and
triple recombination. gph, phosphoglycolate
phosphatase; trpE, anthranilate synthase,
component I; sacB, levansucrase gene
from Bacillus subtilis; neo, aminoglycoside
phosphotransferase from Tn5; epi, mm-CoA
epimerase; mcm, mm-CoA mutase; meaB,
MCM complex protecting protein; lacZ-
zeoR-fusion, b-galactosidase-zeocin resi-
tance fusion.
(B) Integration and genome organization of in-
tegrant P. putida. (Upper panel) DNA frag-
ment of P. putida KT2440 wild-type where
expression plasmid integrates; (middle panel)
expression plasmid; (lower panel) chromo-
somal DNA fragment after integration of ex-
pression plasmid. rpe, ribulose-phosphate
3-epimerase; PP0418, lipase, GDSL family;
trpG, anthranilate synthase, component II;
trpD, anthranilate phosphoribosyl-transfer-
ase; trpC, indole-3-glycerol phosphate
synthase; PP0423, conserved hypothetical
protein; crp, catabolite gene activator Crp.plasmid to be modified [35]. One PCR fragment
employed represents the homology region to the P.
putida chromosome, and the second PCR fragment is
a selectable marker. The resulting plasmid, p15A-
sacB-neo-mutase-lacZ-zeo, was constructed in two
triple recombineering steps (Figure 3A). Each recombi-
nation step was verified by restriction analysis (data
not shown). The expression plasmid was introduced
by electroporation into P. putida KT2440, and kanamy-
cin-resistant colonies were selected for further analysis.
The integration of the DNA fragment harboring the
mm-CoA biosynthetic genes was verified with colony
PCR. Four primer pairs amplifying fragments distributedover the whole length of the integrated fragment were
used (data not shown). From the 22 analyzed clones,
15 turned out to represent single crossover events,
whereas 7 clones resulting from double crossover
were identified (data not shown). The organization of
the resulting chromosomal region in these double cross-
over integrants is depicted in Figure 3B.
It was not possible to perform an analysis of the engi-
neered P. putida strains for mm-CoA production with
the method described by Murli et al. [36] by labeling
the acyl-CoA pool in the cell via 14C-labeled b-alanine.
Wild-type and recombinant P. putida cultures rapidly
converted b-alanine into the gas phase (Figure 4). The
Heterologous Biosynthesis of Methylmalonyl-CoA
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P. putida FG2005 Cultures
Metabolization of the radioactive label. Inset:
14CO2 liberation from the culture.emitted CO2 of the culture was trapped with KOH solu-
tion in a special culture vessel and subsequently ana-
lyzed. The emission of labeled CO2 was in accordance
with the loss of radioactivity in the cells and the super-
natant (Figure 4, inset).
It was thus necessary to develop a new method for
mm-CoA analysis. We chose to use a GC/MS method
based on the procedure described by Salanitro and
Muirhead [37], in which methylmalonate and its CoA
ester are converted into the dibutyl ester (diBE) of meth-
ylmalonic acid (mm) after extraction. Methylmalonic
acid dibutyl ester (mmdiBE) was then quantitatively
analyzed by GC/MS based on an isotope dilution assay
with an authentic reference standard, which enabled
detection of mm down to 1 nmol per sample (see Exper-
imental Procedures). The double crossover strain,
FG2005, was analyzed for mm-CoA production during
the growth phase in duplicates in a time course (Fig-
ure 5). mm-CoA content reached a stable level of
approximately 0.66 nmol/OD unit after 80 hr of incuba-
tion (Figure 5). No mm-CoA could by detected in any
sample derived from the wild-type. The mm-CoA pro-
duction of P. putida FG2005 was also tested in PMM,
a minimal medium, with succinate, the substrate of the
MCM reaction, as sole carbon source. Under these con-
ditions, mm-CoA was not detectable (data not shown).
Production of the mm-CoA-Dependent
Myxobacterial Secondary Metabolite, Myxothiazol,
in P. putida FG2005
To test FG2005 for heterologous production of a second-
ary metabolite that requires mm-CoA, an integrative ex-
pression vector with the myxothiazol biosynthetic gene
cluster [24, 38] was introduced into P. putida FG2005 by
conjugation. Briefly, the myxothiazol biosynthetic gene
cluster [39] was reconstituted from two cosmids on
a single copy vector. Then, the inducible Pm promoter
was inserted in front of the operon, and all genetic ele-
ments required for transfer and integration intoP. putida
were added by recombineering. The complete integra-
tion of the myxothiazol biosynthetic genes into P. putidawas verified by colony PCR, amplifying parts of mtaB,
mtaE, and mtaG (data not shown), and positive clones
were designated P. putida FG2005::Pm-mta. Several
clones were subsequently analyzed for production by
LC-MS in comparison to P. putida KT2440 wild-type
andP. putidaKT2440 harboring the myxothiazol biosyn-
thetic gene cluster as control experiments. Myxothiazol
A was identified by comparison to authentic reference
standard. Only extracts from P. putida FG2005::Pm-
mta were positive for myxothiazol formation (Figure 6),
at a yield of 4.5–5.0 mg/l. Rational optimization of the pro-
duction with different media and supplements increased
the yield significantly. Based on the facts that vitamin
B12 is needed as cofactor for MCM, and that isova-
leryl-CoA is employed as the starter unit of myxothiazol
biosynthesis, it seemed likely that the availability of
these metabolites limits production. Consequently,
Figure 5. Methylmalonate Detection in a P. putida FG2005 Culture
with GC/MS
(a) Methylmalonate content in the culture at given time points per
OD unit; concentration for the whole extract was calculated from
the value of the sample, then divided by the OD600 value. Closed
circles, mean of 2 measurements.
(b) Cell density of the culture in OD600 units at the respective time
points. Closed squares, single measurement of OD.
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thiazol in P. putida FG2005::Pm-mta
(A) HPLC chromatograms of (Aa) HPLC-MS
base peak chromatogram (BPC) of the refer-
ence substance, and (Ab) BPC displaying
intensity of fragments generated from parent
ion of m/z = 400–600 in extracts of P. putida
FG2005::Pm-mta.
(B) mass fragmentation pattern. (Ba) Mass
spectrum of reference substance myxothia-
zol A; (Bb) fragmentation pattern generated
from peak at 28.9 min in (Ab).a minimal medium with addition of L-leucine and vitamin
B12 was used to cultivate P. putida FG2005::Pm-mta, re-
sulting in a production level of 600 mg/l (data not shown).
Discussion
Natural products are a valuable source of compounds
with biological activities [4], and new resources for
such compounds are gaining attention. A prerequisite
for the exploitation of resources, such as ‘‘silent’’ gene
clusters from sequenced genomes or metagenomic
libraries, is the availability of heterologous expression
systems [5, 9, 40, 41]. From heterologous expression
of known biosynthetic gene clusters in E. coli, S. livid-
ans, P. putida, and B. subtilis, it is evident that each
system has limitations, so that successful expression
has only been achieved with gene clusters from closely
related microorganisms [40]. Streptomycetes and re-
lated actinomycetes are the most widely used systems
for heterologous expression [42] because they provide
the whole machinery for polyketide synthesis, and
most known secondary metabolite biosynthetic gene
clusters originate from this genus [5]. The use of E.
coli, favored because of the existing genetic tools, fer-
mentation knowledge, and ease of handling, requires
a lot of strain engineering [10, 43], and there is still thedisadvantage of the different G+C content compared
with that of most biosynthetic gene clusters. The gap
between the more laborious streptomycetes and
E. coli was recently filled with the heterologous expres-
sion of the myxobacterial natural product, myxochro-
mide, in P. putida. A PKS/NRPS hybrid molecule was
produced in P. putida in a 5-fold higher yield in compar-
ison to the natural producer, while fermentation time
was reduced 3-fold [11]. Pseudomonads combine the
advantages of E. coli, like easy handling, genetic tools,
and comparable growth rates, with the properties of
streptomycetes and myxobacteria, like high G+C con-
tent and their ability to produce secondary metabolites.
In addition, they express a broad-range phosphopante-
theinyl transferase for the posttranslational activation of
the carrier protein [12, 44], which is lacking in E. coli.
However, both organisms fail to produce mm-CoA, an
extender unit often used in polyketides [15, 30]. An
mm-CoA-negative strain can be enabled to synthesize
polyketides, which require mm-CoA as an extender
unit by expressing MCM and mm-CoA epimerase. The
epimerase is necessary, because, according to the
published data, only (2S)-mm-CoA is a substrate for
PKS. Dayem et al. [43] engineered an E. coli strain to
produce 6-dEB by inserting the T7 promoter-driven,
broad-spectrum phosphopantheinyl transferase, sfp
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thetase and providing on a plasmid the genes for MCM
and mmCoA epimerase fromP. freudenreichii. On a sec-
ond plasmid, the genes encoding deoxyerythronolide B
synthase were introduced into the heterologous host
[43]. This way, they provided the starter unit, pro-
pionyl-CoA, by feeding propionate to the culture, which
is converted by PrpE to the CoA-ester, and the mm-CoA
extender units are supplied by the MCM and mm-CoA
epimerase.
In order to enable P. putida to produce heterologous
secondary metabolites, which require mm-CoA for their
biosynthesis, the mm-CoA biosynthetic pathway from
a myxobacterium was introduced into this strain. An
operon consisting of three ORFs was identified in the
ongoing sequencing project of S. cellulosum So ce56,
where the first and second ORF exhibit significant simi-
larities to the mm-CoA epimerase and MCM, respec-
tively, of P. freudenreichii shermanii.
MCM is a member of the small family of enzymes using
vitamin B12 to create a substrate radical to exchange
a hydrogen atom with a group attached to the neighbor-
ing carbon atom. Native MCM appears as a dimer; how-
ever, some are homodimers (e.g., Sbm from E. coli [30])
and others are heterodimers of homologous subunits
(e.g., the mutase of P. freudenreichii shermanii [28]).
The expression of the coenzyme B12-dependent MCM
from P. freudenreichii shermanii in E. coli led to the
production of mm-CoA; however, the addition of hy-
droxocobalamin (a precursor in vitamin B12 biosynthe-
sis) to the culture medium was necessary [43], because
E. coli lacks the cobI genes, required for cobalamin for-
mation. In contrast, all genes necessary for cobalamin
production are present in the genome of P. putida
KT2440 (http://www.tigr.org/), which favors the heterol-
ogous expression of MCM in this strain.
When the putative epimerase was used as the query in
a BLASTP search, the best hits were glyoxylases and
bleomycin resistance genes, both of which belong to
the LGSH lyase family. This family is a member of the
vicinal oxygen chelate superfamily, which, in addition
to mm-CoA epimerase, encompasses extradiol dioxy-
genases, and the fosfomycin resitance protein [46, 47].
Members of a superfamily typically share a common
structural scaffold, but may catalyze totally different
overall reactions [47]. Taking this into account, auto-
mated annotations of an ORF as a glyoxylase or bleomy-
cin resistance gene in microbial genome projects should
be reviewed carefully.
The deduced peptide sequence of MCM aligned well
with sequences in the databases (Figure 2B). A data-
base search for MCMs at UniProt (http://www.ebi.
uniprot.org/index.shtml) revealed 284 entries compris-
ing sequences ranging from 1139 to 58 amino acids in
length. A total of 19 of these peptide sequences repre-
sent proteins with more than 1000 amino acid residues.
These peptides contain also an additional ArgK domain.
The ArgK protein, annotated as MeaB in S. cellulosum
So ce56 genome, is present in the operon described
here as a separate gene, and not similar to the additional
N terminus of MCM (Figure 2B). The MCM of S. cellulo-
sum So ce56 represents the largest known mutase with-
out the ArgK domain on the same peptide. This may be
due to the fact that the first 150–200 amino acid residuesof the peptide chain show a weak similarity (around 30%
identity) to MCM small subunits. The impact of this
N-terminal extension on the function of the enzyme is
not clear at present.
The third gene in the operon, meaB, was initially iden-
tified as a homolog to ArgK of E. coli, an ATPase enzyme
belonging to the LAO transport proteins. This annotation
was later challenged, since many ArgK homologs
cluster with MCM, and participation in the propionyl-
CoA pathway was assumed. Recently, MeaB, a homolog
in Methylobacterium extorquens AM1, was shown to
protect the MCM complex from inactivation [48]. It was
shown that MeaB is not a reactivation factor for MCM,
as it is known for the B12-dependent diol dehydratase
and glycerol dehydratase [49, 50]. It was suggested
that MeaB protects MCM from suicide inactivation by
forming a complex [48] and preventing the observed
dissociation of subunits [51]. The bound cofactor in
the dissociated subunits is supposed to be exposed to
O2, water, or highly reactive radical intermediates, and
the inactive form of MCM is generated [51].
If a gene or a cluster of genes and their respective
peptides are subjected to biochemical studies, PCR
from the respective extrachromosmal DNA entity or
chromosomal DNA is currently used, most often, to
clone the ORF into expression vectors. This method
has limitations if the DNA fragments to be amplified
are of large size, and Red/ET subcloning circumvents
these limitations [33]. Large stretches of DNA can be
subcloned in a fast and simple way by this method (Fig-
ure 3A), and only the regions encompassing the PCR
primers have to be sequenced to ensure the fidelity of
the primers and the correctness of the recombination.
With the applied triple recombination technique in the
downstream construction of the integrative expression
plasmid, engineering of a DNA molecule becomes
even more liberated from constraints of ‘‘classical’’
DNA manipulation technologies. It provides a one-step
procedure to introduce a DNA fragment at a desired
location in the molecule (Figure 3A).
Once the mm-CoA operon was introduced into P.
putida, a method for the detection of the compound
was needed. The failure of the simple and elegant
method described by Murli et al. [36], which records
the complete acyl-CoA ester pool in a cell through the
labeling of coenzyme A with radioactive b-alanine, was
most likely caused by the presence of a b-alanine::pyru-
vate transaminase, au-transaminase, which is not pres-
ent in E. coli. A corresponding gene was found in the
genome of P. putida KT2440 (PP0596). The encoded
protein is part of the reductive degradation pathway of
pyrimidines [13]. Malonate semialdehyde, the desami-
nation product of b-alanine, is probably metabolized
immediately by the Krebs cycle, and, therefore, the
labeled b-alanine added to the culture broth almost
exclusively ended up in CO2. We then developed an
alternative isotope dilution assay for the analysis of
mm-CoA by GC/MS, based on the conversion of short-
chain carboxylic acids into their corresponding butyl
ester (BE), as described by Salanitro and Muirhead
[37]. There is no need for the expensive, labeled b-ala-
nine, and very sensitive quantitation is possible by the
isotope dilution assay. This method is also not affected
by the presence of a u-transaminase, and, therefore, is
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is indirect in only detecting derivatized compounds, and
not the CoA esters directly, resulting in the inability to
distinguish between epimers of mm-CoA.
In a proof-of-principle experiment, the myxothiazol
biosynthetic pathway from S. aurantiaca DW4/3-1 [24]
was introduced into the recombinant strain, P. putida
FG2005. In contrast to the wild-type, this strain enabled
the production of myxothiazol, which validates the in sil-
ico annotation of the mm-CoA epimerase, because the
extender unit in polyketide biosynthesis is exclusively
the (2S)-isomer of mm-CoA [52]. As shown in Figure 1,
succinyl-CoA is converted by MCM into the (2R)-isomer
of mm-CoA. (2R)-mm-CoA is then racemized into the
(2S)-isomer by the epimerase. This means that the
enzymes of the introduced mcm-operon in P. putida
FG2005 are functional in the proposed manner because
the polyketide myxothiazol was synthesized.
The conversion of propionyl-CoA to succinyl-CoA via
the MCM pathway is the most common and best-estab-
lished pathway [53].P. putida is able to grow on L-valine/
L-isoleucine as the sole carbon source; however, we
were not able to detect mm-CoA (data not show). There-
fore, we assume that pseudomonads use one of the
other described pathways not involving mm-CoA [53].
The initial yield of 4.5–5.0 mg/l myxothiazol achieved by
heterologous expression in P. putida FG2005 after culti-
vation in LB medium is about half the amount of the re-
ported heterologous production of the myxobacterial
secondary metabolite, epothilone, in E. coli (w10 mg/l)
[54]. However, the required strain engineering and the
construction of the expression vector was less laborious.
Importantly, the starter unit of myxothiazol biosynthesis,
isovaleryl-CoA, is a metabolite derived from the degrada-
tion of the amino acid L-leucine [13]. This is likely one rea-
son for the low production yield, because the degrada-
tion pathway is only active after induction (e.g., during
growth on minimal medium with L-leucine as the sole car-
bon source). Another possibility for the bottleneck of pro-
duction is the supply of the required extender mm-CoA,
which may be caused by a shortage of the MCM cofactor,
vitamin B12 (compare with [55]). Consequently, we could
show that production in a minimal medium based on
L-leucine as a carbon source, with the addition of vitamin
B12, increased production more than 120-fold, reaching
levels of 0.6 mg/l (typical yields in myxobacterial pro-
ducers are below 10mg/l). Experiments aimedata further
increase of the biosynthesis of mm-CoA (e.g., to change
the TTG starter triplet ofmeaB into ATG) are under way in
our laboratory. An increase of the mm-CoA production
level after this change might be possible owing to a better
expression of MeaB, which would also strengthen the
possibility that this protein protects the MCM enzyme
complex from inactivation [48].
Significance
We identified, in silico, in theSorangiumcellulosumSo
ce56 genome, an operon consisting of three genes—
methylmalonyl-CoA (mm-CoA) epimerase (epi);
mm-CoA mutase (mcm); and meaB—responsible for
mm-CoA production. The operon was subcloned and
heterologously expressed in Pseudomonas putida
KT2440, which is unable to produce mm-CoA, anextender unit required for the production of a variety
of secondary metabolites. The production of the com-
pound was verified and quantitatively analyzed by an
isotope dilution method based on GC/MS analysis of
the respective diBE. This method can be applied to all
microorganisms, because it is not sensitive to the
presence of ab-alanine::pyruvate transaminase, which
made the use of a previously published method impos-
sible based on feeding of radioactive b-alanine to label
the acyl-CoA pool of the cell. In a proof-of-principle ex-
periment, the biosynthetic gene cluster coding for the
myxothiazol PKS/NRPS hybrid, megasynthetase, was
heterologously expressed in the P. putida strain pro-
ducing mm-CoA. The engineered P. putida strain pro-
vides an additional expression system for secondary
metabolite production aside from Escherichia coli or
streptomycetes to explore the possibilities of metage-
nomes, silent gene clusters, or gene clusters from
slow-growing organisms for the production of new
and altered metabolites with biological activities.
Since the parent strain is well characterized, easy to
genetically manipulate, and completely sequenced, it
should be possible to improve the strain even more
by precise genome engineering.
Experimental Procedures
General cloning procedures and DNA manipulations were carried
out as described by Sambrook et al. [56]. Red/ET recombineering
was performed in E. coli HS996, also known as GeneHogs E. coli
(ResGen; Invitrogen Corporation, Karlsruhe, Germany). Restriction
endonucleases were purchased from New England Biolabs (Frank-
furt am Main, Germany) and used according to the instructions of
the manufacturer. P. putida KT2440 [57] was used as heterologous
expression host for the mm-CoA biosynthetic operon. E. coli and
P. putida were normally grown in LB medium [58]. For the analysis
involving 14C-labeled b-alanine, P. putida FG2005 was grown in
M medium [59]. For mm-CoA production and GC/MS analysis,
P. putida FG2005 was fermented in LB medium, PMM medium
[60], or minimal medium (1.5 g/l K2HPO4, 0.5 g/l KH2PO4, 0.2 g/l
MgSO4 3 7H2O, 2 g/l NaCl, 1 g/l (NH4)2SO4, 25 mM L-valine, 7 mM
L-isoleucine). L-leucine was added to this minimal medium in the
same concentration as L-Isoleucine. This medium was supple-
mented with 0.1 mg/l vitamin B12 if needed.
Identification and Subcloning of the mm-CoA Biosynthesis
Operon in S. cellulosum So ce56
The contigs of the preliminary S. cellulosum So ce56 genome se-
quence available at the time of investigation were analyzed with
the BLASTP software [26] employing the amino acid sequences of
the large and small subunits of MCM and mm-CoA epimerase
(P11653, P11652, and AY046899, respectively) of P. freudenreichii
shermanii as query sequences. One contig was identified harboring
all homologs to the query sequences. The insert end sequences of
a BAC library of S. cellulosum So ce56 [16] were analyzed with
BLASTP with the identified contig as query to identify a BAC clone
harboring the operon. Three independent clones were identified
with this procedure: 1$1 F5, 4 D8 and 1$4 C7. The operon was subcl-
oned on a minimal p15A-replicon with Red/ET recombineering [61].
The minimal replicon was amplified with primers mutasub5 (50-
TGCGCGCCGCGCGGCAGCTGCTGGAGGCCTGGAATCCGGCCGG
AAAGCGCTGATCGTGCTGACGCTTCATCAGAAG -30) and muta-
sub3 (50-TCGGGAGGCCGGTCGGGGCTGCAGGGGCCGGCCGTGT
CGCGGGGGGCGCCATGCGCTAGCGGAGTGTATACTGG-30) from
plasmid pACYC177 [62], with the respective homology arms (under-
lined) to the target sequence on the BAC. The amplicon was used in
the Red/ET subcloning procedure [33] to yield plasmid p15A-amp-
mutase (Figure 3A). The following construction steps for creating
an integrative plasmid were carried out in a procedure termed ‘‘triple
recombination,’’ because three DNA fragments are involved in the
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fragments were used; the two PCR fragments overlap by 50 bp. A
similar procedure was recently used for a chromosomal promoter
replacement in E. coli [35]. First a gph0-sacB-Tn5neo cassette was
introduced 50 to the mcm operon. The partial gph fragment (phos-
phoglycolate phosphatase) from P. putida (see Figure 3B) was
amplified with primers homtrp5 (50-TGACACCCTCATCAGTGCCAA
CATAGTAAGCCAGTATACACTCCGCTAGCGCTTAAGTGCTGGAC
CAGATGAAGATCGGTA-30) and homtrp3 (50-TCGACCTCATTCTAT-
TAGACTCTCGTTTGGATTGCAACTGGTCTAGAGTAGTCTCGTGGC
AAGCAGCAATAG-30) from genomic DNA, and the sacB-neo frag-
ment with primers trpsacB5 (50-TGCCTGACCTATTGCTGCTTGCC
ACGAGACTACTCTAGACCAGTTGCAATCCAAACGAG-30) and trpsacB3
(50-TGGGTCGGGAGGCCGGTCGGGGCTGCAGGGGCCGGCCGTG
TCGCGGGGGGCGCCATGATTAGTTCCTCAGAAGAACTCGTCAAG
AAGG-30) from plasmid pIB279 [63]. Both PCR fragments were
coelectroporated into recombineering-proficient E. coli HS996/
p15A-amp-mutase, pSC101BADgbaA [64]. The resulting plasmid
was designated as p15A-amp-sacB-neo-mutase (Figure 3A). In
a second step, a lacZ-zeoR-trpE0 cassette was introduced down-
stream of the mcm-operon. The lacZ-zeoR fusion was amplified
with primers laczeom5 (50-TGCGCGCCGCGCGGCAGCTGCTGGAG
GCCTGGAATCCGGCCGGAAAGCGCTGAGGAATCAATCATGGTC
GCGAGTAGCTTGGCACTGGCCGTCGTTTTACAACGTCGTGAC-30)
and laczeom3 (50-TAGCCGGCAGCGGCCAGGCGCAGGAATTCTTC
GCGGTTCATTCAGTCCTGCTCCTCGGCCACG-30) from plasmid
pGT-IRES-lacZ-zeo (unpublished data), and the partial trpE-frag-
ment (anthranilate synthase, component I) as second homology
region to the P. putida genome, with primers lacztrp5 (50-TGGCCG
AGGAGCAGGACTGAATGAACCGCGAAGAATTCCTGCGC-30) and
lacztrp3 (50-TGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAAC
TTGGTCTGACAGCTTAAGAAGGCCTGATCTTCAGCTGGGTC-30)
from genomic DNA. The priming sites are underlined, and artificially
introduced restriction site AflII in homtrp5 and lacztrp3 are depicted
in italics. The two PCR products were coelectroporated into
a recombeneering-efficient E. coli/p15A-amp-sacB-neo-mutase,
pSC101BADgbaA [64]. The correct clones were identified by restric-
tion digest after each recombination event. The final construct was
designated as p15A-sacB-neo-mutase-lacZ-zeo (Figure 3A).
The sequence of the described mm-CoA biosynthesis operon is
deposited at EMBL nucleotide sequence database, with accession
number AM260198.
Integration of the mmCoA Operon into P. putida KT2440
Genome
The expression plasmid was transformed intoP.putidaby electropo-
ration, and kanamycin-resistant clones were selected. The electro-
competent cells were prepared as follows: 1.4 ml LB medium in
a 1.5 ml reaction tube were inoculated with 30 ml of a saturated over-
night culture of P. putida KT2440 and incubated for 2 hr at 28C with
shaking on a thermomixer (Eppendorf, Hamburg, Germany). The
cells were washed twice with ice-cold water and resuspended after
the last washing step in the remaining drop of liquid. A 1 ml aliquot
of a plasmid minipreparation of p15A-sacB-neo-mutase-lacZ-zeo
was added, and the cell suspension was transferred to a 1 mm elec-
troporation cuvette. The cells were pulsed with a voltage of 1.1 kV in
an Eppendorf electroporator model 2510 (Eppendorf); then, 500ml LB
medium was added, the cells transferred to a 1.5 ml reaction tube and
incubated for 60 min at 30C, with shaking for phenotypic expression
on a thermomixer. The transformed cells were spread on LB agar
containing 15 mg/ml kanamycin and incubated at 30C overnight.
To further verify the clones, four internal primer pairs were used for
colony PCR reaction (integrchk1-5: 50-GGACCAGATGAAGATCGGT
A-30 and integrchk1-3: 50-TGTTCATCGTTCATGTCTCC-30; integrchk2-
5: 50-CGACTTCCAGTTCAACATCA-30 and integrchk2-3: 50-GATTCGA
GCAGGTACGAGTT-30; mutasechk3-5: 50-GCTTCGCCCACGTCGCC
TACC-30 and mutasechk3-3: 50-CGACGATGCCGCGGAGGAGGTT-
30; mutasechk4-5: 50-CGAGACGGGCGAGGGGAACC-30 and muta-
sechk4-3: 50-CGTCTTGTCGCCGAGGATGCT-30; data not shown).
Analysis of Clones for mmCoA Production with 14C-Labeled
b-Alanine
The uptake of the 14C label into the cells was examined in a 10 ml
culture of P. putida FG2005 in M medium with 0.1 mCi b-alanine(Amersham, Freiburg, Germany) in a 100 ml Erlenmeyer flask, incu-
bated at 30C in a water bath with agitation. At indicated time points
(Figure 4), two 0.1 ml samples were taken. One sample was centri-
fuged to separate cells from supernatant, and 50 ml of the superna-
tant was analyzed with a Beckman LS 6500 scintillation counter
(Beckman Coulter, Krefeld, Germany). A 50 ml aliquot of the second
sample was analyzed without any further manipulation with the scin-
tillation counter.
The liberation of 14C-labeled CO2 was measured with 10 ml of an
overnight culture of P. putida FG2005. The culture was transferred
into an Erlenmeyer flask-like vessel, which had a small cylinder at
the bottom. A 47 % KOH solution was added to this cylinder to
absorb the liberated CO2. After adding 0.1 mCi b-alanine, the vessel
was sealed with a screw cap containing a silicon membrane and
incubated at 30C in a water bath with agitation. Every 15 min,
a 50 ml sample of the KOH solution was taken with a Hamilton syringe
through the membrane and analyzed in a scintillation counter.
Analysis of Clones for mmCoA Production with GC/MS
A 100 ml LB sample supplemented with 50 mg/ml kanamycin was
inoculated 1:1000 with an overnight culture of P. putida FG2005,
incubated at 30C and 180 rpm on a Multitron rotary shaker (Infors
AG, Bottmingen, Switzerland), and harvested at different time
points. The cells were collected by centrifugation. The cell pellets
were frozen in liquid nitrogen and stored at 280C until further
processing. For extraction, the pellets were thawed on ice, resus-
pended in 1–2 ml PBS buffer (PBS tablets; Invitrogen) and the cell
lysates were prepared with a French press. After addition of 50 ml
methanol, the suspension was incubated 1 hr with agitation and
then filtered through a folded paper filter. The methanol buffer
mixture was removed in vacuo, and the residue dissolved in 1 ml
methanol.
Methylmalonic acid and its CoA ester were transformed into
mmdiBE by a procedure based on the method of Salanitro and Muir-
head [37]. An aliquot (300 ml) of the extract was transferred to a glass
vial (1.8 ml), 10 nmol of the internal standard, methyl-d3-malonic
acid, was added, and the mixture was evaporated to dryness in
a vacuum concentrator (Eppendorf), and 400 ml hexane and 100 ml
HCl (w3 M) in 1-butanol (Fluka, Taufkirchen, Germany) were added
to the dry sample. The vials were capped with Teflon-lined screw
caps and incubated at 80C for 2 hr. After cooling down to room tem-
perature, the reaction mixture was neutralized with 500 ml of an
aqueous solution of Na2CO3 (6% m/V), and the vials were centri-
fuged to achieve complete phase separation. The upper organic
phase was injected into the gas chromatograph. All quantitations
were carried out in duplicate unless otherwise stated. Samples
were measured on an Agilent 6890N gas chromatograph equipped
with a 5973N mass selective detector and a 7683B automatic liquid
sampler (Agilent Technologies, Waldbronn, Germany). The station-
ary phase was an HP-5ms capillary column (0.25 mm 3 30 m 3
0.25 mm, dimethylpolysiloxane with 5% phenyl rests; Agilent Tech-
nologies), and the carrier gas was helium, at a flow rate of 1.5 ml/
min. The temperature gradient we used was as follows: 70C for 5
min (isothermal), heating up to 170C at 5C/min, heating up to
300C at 30C/min, 300C for 5 min (isothermal), then cooling
down to 70C at 30C/min. We used a pulsed, splitless injection
mode, injecting 2 ml of sample. For quantitation, the mass detector
was configured for single-ion monitoring, scanning ions m/z 101,
104, and 105 at a dwell time of 100 ms/ion. The quantitation was
based on the ratio of the areas of the ions m/z 101 (mmdiBE) and
m/z 104 (methyl-d3-malonic acid diBE). Calibration was done with
triplicate samples of 1, 2, 5, 10, 20, and 50 nmol methylmalonate,
each sample containing 10 nmol methyl-d3-malonate. Data analysis,
calibration, and quantitation were done with Agilent ChemStation
software. Based on the values obtained by this method, methylmal-
onate quantities were calculated in nanomoles per OD unit.
Conjugation of a Myxothiazol Expression Plasmid
into P. putida FG2005
The integrative myxothiazol gene cluster expression vector [24, 38]
was introduced into the chromosome of the P. putida KT2440
wild-type as well as into the chromosome of the mm-CoA-generat-
ing P. putida FG2005 by triparental conjugation, as described previ-
ously [65]. The selection was carried out on PMM agar plates
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with the myxothiazol biosynthetic genes, or tetracycline and kana-
mycin (50 mg/ml) to perform selection for the clones containing
myxothiazol genes in the mm-CoA-producing P. putida FG2005.
The obtained clones were tested by colony PCR (Taq-polymerase;
Invitrogen) with myxothiazol-specific primers designated for differ-
ent parts of the gene cluster (parts of mtaB: 50-GAACGTGGTCGTC
TCGGGAG-30 and 50-CGAATCACCAGCCCGGAGAC-30, mtaE: 50-
TCAAGCCGGATGAGGTCTAC-30 and 50-CTTGGACACGGTATCGA
GGT-30 and mtaG: 50-CTCTTCTTCATGCATCCGAC-30 and 50-CCGG
TACATCTGAACCTGCT-30) to verify the integration of the whole
biosynthetic gene cluster into the chromosome (data not shown).
Analysis of the Heterologous Myxothiazol Production
in P. putida
The P. putida strains were inoculated with a respective overnight
culture (1:100) and incubated in 300 ml flasks containing 50 ml LB
medium supplemented with tetracycline (25 mg/ml) and with 2%
XAD 16 (Rohm und Haas, Frankfurt am Main, Germany) for 1–2 hr
at 30C with shaking. Myxothiazol production was induced by the
addition of toluic acid (5 mM); the culture was transferred to 16C
and incubated for 2–3 days. The cells and resin were harvested by
centrifugation and extracted with acetone and methanol. The
extracts were evaporated and resuspended in 1 ml methanol; 5 ml
of the extracts was analyzed by LC-MS. The chromatographic con-
ditions were: RP column Nucleodur C18, 125 3 2 mm, 3 mm, and
precolumn C18, 8 3 3 mm, 5 mm. Solvent gradient (with solvents A
[water and 0.1% formic acid] and B [acetonitrile and 0.1% formic
acid]) from 5% B at 2 min to 95% B within 30 min, followed by 4
min with 95% B at a flow rate of 0.4 ml/min. The mass was detected
in positive ionization mode. Myxothiazol A was identified by com-
parison to the retention times and the MS data of the reference sub-
stance ([M+H]+ = 488) (Figure 6). For quantitative analysis, samples
were separated on a gradient starting at 80% B and running to
95% B at 5 min, with elution of myxothiazol A occurring at 3 min.
Quantitation was carried out in manual MS2 mode. Ions of m/z
[M+H]+ = 488 were collected and subjected to fragmentation. The
intensities of characteristic fragment ions m/z = 456 and m/z = 439
were summed up, and peak integration was carried out utilizing
the Bruker QuantAnalysis v1.6 software package. A calibration
curve was established from serial dilutions of myxothiazol A down
to 0.1 mg/ml. Samples under investigation were diluted as required
to fit the dynamic range of the method.
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